Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTheworks.co.uk. Regulatory News (WRKS)

Share Price Information for Theworks.co.uk. (WRKS)

Share Price is delayed by 15 minutes
Get Live Data
66.60    0.00 (0.00%)
Bid:
65.00
Ask:
68.20
Spread: 3.20 (4.923%)
Market Cap: £39.54m
WRKS Live PriceLast checked at - London Stock Exchange

Intraday Theworks.co.uk. Share Chart

Chair succession

27 Jun 2024 07:00

RNS Number : 0556U
TheWorks.co.uk PLC
27 June 2024
 

27 June 2024

TheWorks.co.uk plc

("The Works", the "Company" or the "Group")

Chair succession

Carolyn Bradley to step down as Chair of The Works; Steve Bellamy appointed as successor.

TheWorks.co.uk plc, the family-friendly value retailer of arts, crafts, toys, books and stationery, announces that Carolyn Bradley will be stepping down as Chair and Independent Non-Executive Director with effect from 15 July 2024. Steve Bellamy has been appointed to succeed Carolyn and will join the Board on the same date.

Carolyn was appointed Chair of The Works three years ago. During her tenure, Carolyn has helped to steer the business through its recovery from the COVID-19 pandemic and a cyber security incident in April 2022. The business has benefitted greatly from her strong retail, marketing and customer proposition experience, particularly during a period of continuing development of the brand and 'better, not just bigger' strategy. She leaves the business in a stable position following its successful transition to AIM, action taken to reset the cost base and a restructuring of the Operational Board.

Steve Bellamy joins as Non-Executive Chair, bringing extensive experience as both Chair and Non-Executive Director, having worked in and advised a wide range of public and private companies and been Chairman of, and advisor to, investment committees and capital providers. He has a record of supporting leadership teams to execute their operational strategies and in creating shareholder value. He is the Senior Independent Director and Chair of the Audit Committee at Caffyns plc and Independent Non-Executive Director and Chair of the Audit Committee at Empresaria Group plc. Steve's previous roles included being Non-Executive Director of Advanced Medical Solutions Group plc and Michelmersh Brick Holdings plc, and Chair of Becrypt Limited and Concirrus Limited. Steve was also formerly Chief Operating Officer and Finance Director of Sherwood International plc and is a Chartered Accountant.

Steve will become Chair of the Nomination Committee and member of both the Remuneration and Audit Committees upon his appointment to the Board.

Carolyn Bradley, outgoing Chair of The Works, said: "It has been an enormous privilege to Chair The Works and to support Gavin and his leadership team. The Works has demonstrated great resilience in the face of challenging circumstances and I am proud of the transition it has made to become a more purpose-led, customer-oriented business. I leave The Works as it enters a new chapter and with every faith that it will continue on a positive trajectory in the years ahead."

On behalf of the Board, Gavin Peck, CEO of The Works, said: "I am incredibly grateful to Carolyn, who has been a huge support to the business, to colleagues and to me personally in recent years. Her guidance has been invaluable during a period of significant change at The Works and on behalf of all colleagues, we wish her well for the future.

"I look forward to working with Steve as our new Chair, building on the positive commercial and operational momentum we have seen since the start of the year. With the cost saving action taken in recent months and Steve's extensive experience in driving operational improvements and shareholder value, I am confident we will deliver significant profitable growth in the years ahead."

Steve Bellamy, incoming Chair of The Works, said: "The Works is a brilliant business, with a strong value proposition, a quality store portfolio and a tight-knit, energised leadership team. The business has recently undergone a series of changes that lay the foundations for future growth and I look forward to working with the team, under Gavin's leadership, to deliver value creation for shareholders."

Enquiries:

 

TheWorks.co.uk plc

Gavin Peck CEO

Rosie Fordham CFO

 

 

 

via Sanctuary Counsel

Singer Capital Markets (Nomad and Broker)

Peter Steel

Alaina Wong

Jalini Kalaravy

 

020 7496 3000

Sanctuary Counsel

Ben Ullmann

Rachel Miller

Kitty Ryder

 

 

 

0207 340 0395

theworks@sanctuarycounsel.com

 

Additional information in respect of the AIM Rules

The following information regarding the appointment of Stephen Gerard Bellamy (aged 64) is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies ("AIM Rules"):

Current directorships/partnerships

Past directorships/partnerships

Empresaria Group plc

Caffyns plc

Advanced Medical Solutions Group plc

Becrypt Limited

Accretion Capital LLP

As at the date of this announcement, Stephen Bellamy holds 100,000 ordinary shares in the Company.

Save as set out above, there is no further information to be disclosed in respect of Stephen Bellamy under Schedule 2(g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFSLRRIRFIS
Date   Source Headline
26th May 20267:00 amRNS-RInvestor Event - Mello London
22nd May 20267:00 amRNSHolding(s) in Company
21st May 20267:00 amRNSTrading update for the 52 weeks ended 3 May 2026
29th Apr 20269:53 amRNSHolding(s) in Company
24th Apr 20265:55 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20264:20 pmRNSHolding(s) in Company
20th Mar 20267:00 amRNSUpdate regarding online proposition
27th Feb 20265:36 pmRNSHolding(s) in Company
25th Feb 20267:00 amRNSDirectorate Change
22nd Jan 20267:00 amRNSInterim results and Christmas trading update
15th Jan 20267:00 amRNSNotice of Results and Investor Presentation
8th Dec 202511:52 amRNSHolding(s) in Company
27th Nov 20252:19 pmRNSDirectorate Change
13th Nov 20257:04 amRNSDirectorate Change
13th Nov 20257:00 amRNSHalf-year trading update
12th Sep 20253:53 pmRNSDirector/PDMR Shareholding
8th Sep 20252:40 pmRNSResult of AGM
8th Sep 20257:00 amRNSAGM Trading Statement
7th Aug 20251:09 pmRNSPublication of Annual Report and Notice of AGM
1st Aug 20257:00 amRNSDirectorate Change
22nd Jul 20257:00 amRNSPreliminary results - 52 weeks ended 4 May 2025
15th Jul 20257:00 amRNSNotice of Results and Investor Presentation
22nd May 20257:00 amRNSFull Year Trading Update
29th Apr 202512:00 pmRNSDirector/PDMR Shareholding
24th Apr 20257:52 amRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSPurchase of Shares for the Employee Benefit Trust
6th Feb 202512:39 pmRNSHolding(s) in Company
4th Feb 20252:59 pmRNSHolding(s) in Company
31st Jan 20257:00 amRNSDirector/PDMR Shareholding
24th Jan 20257:00 amRNSH1 FY25 results, Christmas trading & new strategy
17th Jan 20257:00 amRNSNotice of Results and Investor Presentation
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSDirectorate Change
31st Oct 202410:00 amRNSResult of AGM and Notice of 2024 Interim Results
8th Oct 202411:09 amRNSNotice of AGM and Publication of Annual Report
3rd Oct 20249:00 amRNSPurchase of Shares for the Employee Benefit Trust
1st Oct 20243:59 pmRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSDirectorate Change
1st Oct 20247:00 amRNSPreliminary results - 53 weeks ended 5 May 2024
23rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
5th Sep 202411:45 amRNSHolding(s) in Company
7th Aug 20246:03 pmRNSHolding(s) in Company
1st Aug 20247:00 amRNSDirectorate Change
15th Jul 20249:58 amRNSHolding(s) in Company
12th Jul 20248:44 amRNSDirector/PDMR Shareholding
4th Jul 202410:50 amRNSHolding(s) in Company
2nd Jul 20247:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.